We propose that the crotonyl-CoA-producing enzyme, acyl-CoA synthetase short-chain family member 2 (ACSS2), could selectively regulate H3K9cr level and function, which represents an attractive drug target for strategies to slow fibrotic kidney disease progression. The gene discussed is ACSS2; the disease is kidney disorder.